Neuregulin-1/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1735-1742

  Matsukawa, Ryuichi ^a   Hirooka, Yoshitaka ^b   Nishihara, Masaaki ^a   Ito, Koji ^a   Sunagawa, Kenji ^a  

^a Department of Cardiovascular Medicine ^*  (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

blood pressure; ErbB; hypertension; neuregulin 1; rostral ventrolateral medulla; sympathetic nervous system

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; ANTIHYPERTENSIVE AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN STEM; CONTROLLED STUDY; DEPRESSOR RESPONSE; ENZYME INHIBITION; HEART RATE; HYPERTENSION; MEDULLA OBLONGATA; NONHUMAN; NORADRENALIN URINE LEVEL; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; ROSTRAL VENTROLATERAL MEDULLA;

EID: 80051939441     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834937d6     Document Type: Article

References (35)

1. Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 2007; 116:954-960. (Pubitemid 47300920)
2. Melenhorst WB, Mulder GM, Xi Q, Hoenderop JG, Kimura K, Eguchi S, van Goor H. Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension 2008; 52:987-993.
3. Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9:437-452. (Pubitemid 351704944)
4. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284:14-30. (Pubitemid 36335807)
5. Rio C, Rieff HI, Qi P, Khurana TS, Corfas G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 1997; 19:39-50. (Pubitemid 27332992)
6. Gerecke KM, Wyss JM, Karavanova I, Buonanno A, Carroll SL. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J Comp Neurol 2001; 433:86-100.
7. Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, Weickert CS. Widespread expression of ErbB2, ErbB3 and ErbB4 in nonhuman primate brain. Brain Res 2007; 1139:95-109. (Pubitemid 46335695)
8. Fox IJ, Kornblum HI. Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions. J Neurosci Res 2005; 79:584-597. (Pubitemid 40476437)
9. Abe Y, Namba H, Zheng Y, Nawa H. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009; 161:95-110.
10. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Muller T, Wende H, et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008; 59:581-595.
11. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007; 54:599-610. (Pubitemid 46756135)
12. Li B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007; 54:583-597. (Pubitemid 46756136)
13. Schmid RS, McGrath B, Berechid BE, Boyles B, Marchionni M, Sestan N, Anton ES. Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc Natl Acad Sci USA 2003; 100:4251-4256. (Pubitemid 36418189)
14. Campos RR, Bergamaschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2006; 2:193-198. (Pubitemid 44304629)
15. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7:335-346.
16. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation. Circ J 2010; 74:827-835.
17. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003; 5:262-268. (Pubitemid 38914970)
18. Schreihofer AM, Guyenet PG. The baroreflex and beyond: control of sympathetic vasomotor tone by GABAergic neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 2002; 29:514-521. (Pubitemid 34535378)
19. Lemmens K, Fransen P, Sys SU, Brutsaert DL, De Keulenaer GW. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 2004; 109:324-326. (Pubitemid 38133898)
20. Zhu WZ, Xie Y, Moyes KW, Gold JD, Askari B, Laflamme MA. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res 2010; 107:776-786.
21. Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, Perng RP. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing nonsmall cell lung cancer cells. Cancer Res 1996; 56:1068-1074.
22. Osherov N, Gazit A, Gilon C, Levitzki A. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J Biol Chem 1993; 268:11134-11142. (Pubitemid 23162303)
23. Ishii Y, Fujimoto S, Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 2006; 174:550-556. (Pubitemid 44330548)
24. Gajendran N, Kapfhammer JP, Lain E, Canepari M, Vogt K, Wisden W, Brenner HR. Neuregulin signaling is dispensable for NMDA-and GABA(A)-receptor expression in the cerebellum in vivo. J Neurosci 2009; 29:2404-2413.
25. Choi BH, Choi JS, Rhie DJ, Yoon SH, Min DS, Jo YH, et al. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor. Am J Physiol Cell Physiol 2002; 282:C1461-C1468. (Pubitemid 34663095)
26. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38:896-901. (Pubitemid 34258689)
27. Hirooka Y, Polson JW, Dampney RA. Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medulla. J Hypertens 1996; 14:1317-1324. (Pubitemid 26377216)
28. Horiuchi J, Dampney RA. Evidence for tonic disinhibition of RVLM sympathoexcitatory neurons from the caudal pressor area. Auton Neurosci 2002; 99:102-110.
29. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109:2357-2362. (Pubitemid 38656873)
30. Grazette LP, Boecker W, Matsui T, Semigran M, Force TL, Hajjar RJ, Rosenzweig A. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol 2004; 44:2231-2238. (Pubitemid 39576044)
31. Sakai K, Hirooka Y, Matsuo I, Eshima K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 2000; 36:1023-1028.
32. Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, Carroll SL. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 2003; 62:42-54. (Pubitemid 36068892)
33. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25:4974-4984. (Pubitemid 40712840)
34. Fischbach GD. NRG1 and synaptic function in the CNS. Neuron 2007; 54:495-497. (Pubitemid 46756150)
35. Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M, et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 2004; 32:e109.